According to Towards Chemical and Materials, the global additive manufacturing with metal powders market volume was valued at ...
AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results